JP2023544404A5 - - Google Patents

Info

Publication number
JP2023544404A5
JP2023544404A5 JP2023520423A JP2023520423A JP2023544404A5 JP 2023544404 A5 JP2023544404 A5 JP 2023544404A5 JP 2023520423 A JP2023520423 A JP 2023520423A JP 2023520423 A JP2023520423 A JP 2023520423A JP 2023544404 A5 JP2023544404 A5 JP 2023544404A5
Authority
JP
Japan
Prior art keywords
compound according
independently
alkyl
cr7r8
appearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023520423A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544404A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/053320 external-priority patent/WO2022076285A1/en
Publication of JP2023544404A publication Critical patent/JP2023544404A/ja
Publication of JP2023544404A5 publication Critical patent/JP2023544404A5/ja
Pending legal-status Critical Current

Links

JP2023520423A 2020-10-06 2021-10-04 Kv1.3カリウムSHAKERチャネル遮断剤としてのラクタム化合物 Pending JP2023544404A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063088171P 2020-10-06 2020-10-06
US63/088,171 2020-10-06
PCT/US2021/053320 WO2022076285A1 (en) 2020-10-06 2021-10-04 LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS

Publications (2)

Publication Number Publication Date
JP2023544404A JP2023544404A (ja) 2023-10-23
JP2023544404A5 true JP2023544404A5 (enExample) 2024-10-16

Family

ID=81126843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023520423A Pending JP2023544404A (ja) 2020-10-06 2021-10-04 Kv1.3カリウムSHAKERチャネル遮断剤としてのラクタム化合物

Country Status (11)

Country Link
US (1) US20230373952A1 (enExample)
EP (1) EP4225285A4 (enExample)
JP (1) JP2023544404A (enExample)
KR (1) KR20230082041A (enExample)
CN (1) CN116782894A (enExample)
AU (1) AU2021358700A1 (enExample)
BR (1) BR112023005387A2 (enExample)
CA (1) CA3193554A1 (enExample)
IL (1) IL301627A (enExample)
MX (1) MX2023003841A (enExample)
WO (1) WO2022076285A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026513122A (ja) * 2022-10-28 2026-04-23 上海深勢唯思科技有限責任公司 芳香族複素環式Kv1.3阻害剤、その製造方法及び用途
EP4700015A1 (en) 2023-04-19 2026-02-25 Shanghai Henlius Biotech, Inc. Heterocyclic ring-substituted aromatic compound, preparation method therefor, and use thereof
WO2025021167A1 (zh) * 2023-07-26 2025-01-30 上海汇伦医药股份有限公司 芳基含氮杂环化合物、药物组合物和应用
WO2025029769A1 (en) 2023-07-31 2025-02-06 Eli Lilly And Company Solid forms of a kv1.3 potassium shaker channel blockers and method of using the same
WO2025235362A1 (en) * 2024-05-06 2025-11-13 D. E. Shaw Research, Llc INDOLINONE COMPOUNDS AS KCa3.1 POTASSIUM CHANNEL BLOCKERS
WO2025235367A1 (en) * 2024-05-06 2025-11-13 D. E. Shaw Research, Llc Azaindolinone compounds as kca3.1 potassium channel blockers
TW202613099A (zh) * 2024-08-08 2026-04-01 大陸商上海美悅生物科技發展有限公司 取代的苯基化合物、及其藥物組合物和用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6174908B1 (en) 1999-05-10 2001-01-16 Icagen, Inc. Potassium channel inhibitors
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
AU2003285952A1 (en) * 2002-10-21 2004-05-13 Irm Llc Pyrrolidones with anti-hiv activity
BRPI0515851A (pt) * 2004-09-29 2008-08-12 Mitsubishi Pharma Corp composto de pirimidona
MX2007008974A (es) * 2005-01-28 2007-09-18 Irm Llc Sintesis de aril-pirrolidonas.
WO2011073273A1 (en) 2009-12-16 2011-06-23 Evotec Ag Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators
CN101979378B (zh) * 2010-10-13 2012-06-27 中国科学院上海有机化学研究所 一种手性γ-内酰胺化合物的合成方法
JP5961187B2 (ja) * 2010-12-20 2016-08-02 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Pi3k阻害剤としてのn−(1−(置換フェニル)エチル)−9h−プリン−6−アミン
WO2015200534A2 (en) * 2014-06-25 2015-12-30 Sanford-Burnham Medical Research Institute Small molecule agonists of neurotensin receptor 1
KR20220079878A (ko) 2019-10-07 2022-06-14 디.이. 쇼우 리서치, 엘엘씨 Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로비시클릭 화합물
KR20220079879A (ko) 2019-10-07 2022-06-14 디.이. 쇼우 리서치, 엘엘씨 Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴메틸렌 방향족 화합물
ES3074115T3 (es) 2019-10-07 2026-07-17 De Shaw Res Llc Compuestos heterocíclicos de arilmetileno como bloqueadores de los canales de potasio tipo Shaker Kv1.3
WO2021071812A1 (en) 2019-10-07 2021-04-15 D.E Shaw Research, Llc Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
IL291867A (en) 2019-10-07 2022-06-01 De Shaw Res Llc Heterocyclic aryl compounds as Shaker kv1.3 potassium channel blockers
IL291868A (en) 2019-10-07 2022-06-01 De Shaw Res Llc Heterocyclic aryl compounds as Shaker kv1.3 potassium channel blockers

Similar Documents

Publication Publication Date Title
JP2022552445A5 (enExample)
JP2019163290A5 (enExample)
JP2025504486A5 (enExample)
JP2022553841A5 (enExample)
JP2021523200A5 (enExample)
JP2022529311A5 (enExample)
RU2018127360A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2010519204A5 (enExample)
ES2752552T3 (es) Métodos de proceso para inhibidores de fosfatidilinositol 3-quinasa
JP2017505808A5 (enExample)
JP2022519239A5 (enExample)
JP2016521710A5 (enExample)
JP2010509342A5 (enExample)
JP2021533087A5 (enExample)
JP2018531218A5 (enExample)
IL308277A (en) Spiroindolinone compounds as kv1.3 potassium shaker channel blockers
JP2024512931A5 (enExample)
EA037643B1 (ru) Замещенные фенилоксазолидиноны для антимикробной терапии
JP2020521739A5 (enExample)
JP2020506906A (ja) Jak酵素阻害剤及びその製造方法と用途
JP2022526553A5 (enExample)
JP2020520925A5 (enExample)
JP2019500374A5 (enExample)
JP2024522718A (ja) 神経変性疾患の治療のための、カルボン酸基を含むアゼチジニル化合物
JP2024533990A5 (enExample)